A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer (NCT07455513) | Clinical Trial Compass
RecruitingNot Applicable
A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer
United States30 participantsStarted 2026-02-25
Plain-language summary
This clinical trial evaluates the feasibility of a novel tobacco cessation resource called a Buckeye Quit Stick among smokers with a diagnosed or suspected thoracic cancer. Tobacco use is the single most preventable cause of disease, disability, and death in the United States. While the benefits of quitting smoking are numerous, rates of persistent smoking after cancer diagnosis remain high. Research has found that patients who quit smoking but subsequently relapse frequently report the hand/oral habit as a barrier to sustained smoking cessation. The Buckeye Quit Stick is an innovative cessation aid designed to directly address patients' hand/oral habit by substituting the cessation aid for cigarettes without integrating pharmacologic intervention, which is typically managed by their medical provider and may require direct supervision due to the patient's health status. The Buckeye Quit Stick is designed to satisfy the repeated hand/oral pattern or ritual, thereby avoiding the physical loss of holding a cigarette in the hand or mouth and the action of smoking. It may also help occupy fidgeting hands and potentially reduce stress and cravings. This novel cessation resource may address key factors that influence smoking abstinence and improve patients' health outcomes.
Who can participate
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* \>= 21 years old
* Speak and understand English
* Established patient of the OSU thoracic clinics
* Diagnosed with a thoracic malignancy or has a clinically suspected thoracic malignancy as documented by treating provider
* Willing and able to participate in the study protocol (e.g., complete the survey and related study documents and provide informed consent)
* Current self-reported smoker
* Willingness to change = score of above 1 on the Stages of Change measure
Exclusion Criteria:
* \< 21 years old (Ohio is a tobacco 21 state.)
* Patient outside of the OSU clinics (This intervention targets patients who may benefit the most from cessation.)
* Unwilling or unable to provide consent or complete study components
* Prisoners will be excluded from participation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial seems to be focused on testing whether a tobacco cessation program is even feasible to run — not yet on whether it definitively helps patients quit — so what does that mean for what I would actually get out of participating compared to standard smoking cessation support you could offer me right now?
2Since I've been diagnosed with or am being evaluated for a thoracic cancer, how important is quitting smoking at this stage of my care, and would joining a study like this actually get me the support I need quickly enough given where I am in my treatment timeline?
3The trial is measuring things like how many people sign up and stick with the program rather than tracking cancer outcomes — so is there any direct medical benefit to me, or would I mainly be helping researchers figure out if the program is worth studying further?
4What does this tobacco cessation resource actually involve in terms of time, appointments, or activities, and is that realistic given everything else I may be going through with my diagnosis and treatment?
5Are there smoking cessation programs or medications already proven to work that I should consider first, and how does this trial compare to those options?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Recruitment rates (feasibility)
Timeframe: Up to 1 year
2
Adherence (feasibility)
Timeframe: at baseline, 2 weeks, 3 months and 6 months
3
Retention rates (feasibility)
Timeframe: At 2 weeks, 3 months, and 6 months
Trial details
NCT IDNCT07455513
SponsorOhio State University Comprehensive Cancer Center
Sponsor typeOTHER
Study typeINTERVENTIONAL
Primary completion2027-03-31
Contact for this trial
The Ohio State University Comprehensive Cancer Center